Charles Schwab’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.55M | Buy |
|
|||||
|
2025
Q2 | $835K | Sell |
|
|||||
|
2025
Q1 | $530K | Sell |
|
|||||
|
2024
Q4 | $880K | Sell |
|
|||||
|
2024
Q3 | $2.23M | Buy |
|
|||||
|
2024
Q2 | $2.28M | Buy |
|
|||||
|
2024
Q1 | $2.11M | Buy |
|
|||||
|
2023
Q4 | $1.32M | Buy |
|
|||||
|
2023
Q3 | $929K | Buy |
|
|||||
|
2023
Q2 | $1.63M | Buy |
|
|||||
|
2023
Q1 | $1.67M | Sell |
|
|||||
|
2022
Q4 | $1.33M | Buy |
|
|||||
|
2022
Q3 | $1.59M | Buy |
|
|||||
|
2022
Q2 | $809K | Sell |
|
|||||
|
2022
Q1 | $1.05M | Buy |
|
|||||
|
2021
Q4 | $1.93M | Buy |
|
|||||
|
2021
Q3 | $2.29M | Buy |
|
|||||
|
2021
Q2 | $2.16M | Buy |
|
|||||
|
2021
Q1 | $2.48M | Buy |
|
|||||
|
2020
Q4 | $1.14M | Buy |
|
|||||
|
2020
Q3 | $425K | Buy |
|
|||||
|
2020
Q2 | $567K | Buy |
|
|||||
|
2020
Q1 | $521K | Buy |
|
|||||
|
2019
Q4 | $1.09M | Buy |
|
|||||
|
2019
Q3 | $697K | Sell |
|
|||||
|
2019
Q2 | $1.69M | Buy |
|
|||||
|
2019
Q1 | $1.48M | Buy |
|
|||||
|
2018
Q4 | $1.72M | Sell |
|
|||||
|
2018
Q3 | $2.84M | Buy |
|
|||||
|
2018
Q2 | $2.89M | Buy |
|
|||||
|
2018
Q1 | $1.94M | Buy |
|
|||||
|
2017
Q4 | $2.17M | Buy |
|
|||||
|
2017
Q3 | $2.51M | Buy |
|
|||||
|
2017
Q2 | $3.18M | Buy |
|
|||||
|
2017
Q1 | $2.75M | Sell |
|
|||||
|
2016
Q4 | $4.34M | Sell |
|
|||||
|
2016
Q3 | $5.7M | Buy |
|
|||||
|
2016
Q2 | $4.38M | Buy |
|
|||||
|
2016
Q1 | $1.82M | Buy |
|
|||||
|
2015
Q4 | $1.99M | Buy |
|
|||||
|
2015
Q3 | $1.55M | Buy |
|
|||||
|
2015
Q2 | $1.06M | Buy |
|
|||||
|
2015
Q1 | $844K | Buy |
|
|||||
|
2014
Q4 | $774K | Buy |
|
|||||
|
2014
Q3 | $840K | Sell |
|
|||||
|
2014
Q2 | $1.06M | Sell |
|
|||||
|
2014
Q1 | $1.24M | Buy |
|
|||||
|
2013
Q4 | $1.25M | Buy |
|
|||||
|
2013
Q3 | $1.77M | Sell |
|
|||||
|
2013
Q2 | $1.94M | Buy |
|